Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial
Authors
Keywords
Chronic myeloproliferative disorders, JAK inhibitor, Polycythemia vera, Ruxolitinib
Journal
ANNALS OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-27
DOI
10.1007/s00277-018-3365-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
- (2017) Francesco Passamonti et al. LANCET ONCOLOGY
- Myeloproliferative Neoplasms
- (2017) Jerry L. Spivak NEW ENGLAND JOURNAL OF MEDICINE
- From leeches to personalized medicine: evolving concepts in the management of polycythemia vera
- (2016) Alessandro M. Vannucchi HAEMATOLOGICA
- Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
- (2016) S. Verstovsek et al. HAEMATOLOGICA
- Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease
- (2016) Holly Geyer et al. JOURNAL OF CLINICAL ONCOLOGY
- The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts
- (2016) Robyn Marie Scherber et al. LEUKEMIA & LYMPHOMA
- How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera
- (2016) Andreas Reiter et al. Current Hematologic Malignancy Reports
- From leeches to personalized medicine: evolving concepts in the management of polycythemia vera
- (2016) Alessandro M. Vannucchi HAEMATOLOGICA
- Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial
- (2016) S. Verstovsek et al. HAEMATOLOGICA
- Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera
- (2015) Alberto Alvarez-Larrán et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- How I treat polycythemia vera
- (2014) A. M. Vannucchi BLOOD
- Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project
- (2013) G. Barosi et al. BLOOD
- Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
- (2013) A Tefferi et al. LEUKEMIA
- Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN
- (2012) Elisabetta Antonioli et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- (2012) Roberto Marchioli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera
- (2011) A. Alvarez-Larran et al. BLOOD
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis
- (2008) F. Passamonti et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now